

Vinay Prasad: Big Pharma should be scared of RFK Jr.
Nov 21, 2024
Vinay Prasad, a hematologist and public health commentator, dives into Robert F. Kennedy Jr.'s potential impact on America's healthcare system. He discusses how RFK Jr.'s controversial views could challenge Big Pharma's grip on policy. Prasad evaluates Kennedy's proposed reforms through a European lens, comparing healthcare practices and addressing misconceptions about European models. The podcast also examines corporate lobbying and the necessity for independent healthcare recommendations, highlighting calls for change amidst a flawed system.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 2min
Navigating Health Policy in a Trump Administration
01:36 • 5min
Evaluating RFK Jr.'s Policies through a European Lens
06:48 • 4min
Corporate Lobbying and Political Dynamics Surrounding Bobby Kennedy's Confirmation
10:29 • 4min
Bobby Kennedy's Vision for Healthcare Reform
14:19 • 14min
Evaluating Nominees: The Trade-off Between Change and Corporatism
28:06 • 3min
Challenging the Status Quo in American Health Policies
31:05 • 2min
Navigating Controversy in Public Health Discourse
33:03 • 3min